Mechanisms of Antiarrhythmic Drug Actions

Nattel S. Mechanisms of antiarrhythmic drug actions. Card Electrophysiol Rev 1998;2:115-118.

Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999;42:298-308.

Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.

Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.

Hobbs WJ, Van Gelder IC, Fitzpatrick AP, Crijns HJ, Garratt CJ. The role of atrial electical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:866-870.

Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999;100:1879-1886.

Haissguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000;101:1409-1417.

Chen SA, Tai CT, Tsai CF, Hsieh MH, Ding YA, Chang MS. Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats. J Cardiovasc Electrophysiol 2000;11:218-227.

Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999;100:87-95.

Garrey WE. Auricular fibrillation. Physiol Rev 1924;4:215-250.

Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation-very new insights into very old ideas. Ann Rev Physiol 2000;62:51-77.

Pham TD, Fenoglio JJ Jr. Right atrial ultrastructure in chronic rheumatic heart disease. Int J Cardiol 1982;1:289-304.

Ohtani K, Yutani C, Nagatta S, Koretsune Y, Hori M, Kamada T. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 1995;25:1162-1169.

Lie JT, Hammond PI. Pathology of the senescent heart: Anatomic observation on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988;63:552-564.

Li D, Shi YF, Levi M, Leung TK, Tardif JC, Nattel S. Prevention of atrial structural remodeling-a potential new approach to treating atrial fibrillation. Circulation 1999;100(suppl):I-11.

Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376-380.

Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardiainduced electrical remodeling of the atria. Circulation 1997;95:1945-1953.

Fareh S, Benardeau A, Nattel S. Comparative study of the efficacy of T-and L-type calcium channel blockers against atrial remodeling due to sustained atrial tachycardia. Circulation 1999;100(suppl): I-11.

Lee SH, Yu WC, Cheng JJ, Hung CR, Ding YA, Chang MS, Chen SA. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 2000;101:200-206.

Fareh S, Benardeau A, Thibault B, Nattel S. The T-type (Ca2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999;100:2191-2197.

Cohen CJ, Spires S, Van Skiver D. Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol 1992;100:703-728.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.